Top

Published in:

01-06-2016 | Original Article

Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway

Authors: Amir Rashidian, Ahad Muhammadnejad, Ahmad-Reza Dehpour, Shahram Ejtemai Mehr, Maziar Mohammad Akhavan, Reza Shirkoohi, Mohsen Chamanara, Seyyedeh-Elaheh Mousavi, Seyed-Mahdi Rezayat

Published in: Inflammopharmacology | Issue 2-3/2016

Abstract

Aim

The aim of the present study is to explore whether atorvastatin improves intestinal inflammation through the inhibition of the TLR4/NFkB signaling pathway in TNBS-induced rat colitis.

Methods

Acute colitis was induced by intra-rectal administration of 100 mg/kg TNBS dissolved in 0.25 ml of 50 % ethanol. Twenty four hours after colitis induction, saline, atorvastatin (20 and 40 mg/kg) and sulfasalazine (100 mg/kg) were given to the animals by oral route. This was repeated daily for 1 week. Body weight changes, macroscopic and microscopic lesions were assessed. MPO and TNF-α activities were detected by immunohistochemistry (IHC) and the expression level of TLR4, MyD88 and NF-κB p65 proteins were measured by western blotting analysis.

Results

Atorvastatin and sulfasalazine reduced the body weight loss, macroscopic and microscopic lesions. Additionally, both drugs decreased the expression of MPO and TNF-α positive cells in the colon tissue. Furthermore, they inhibited the TNBS-induced expression of TLR4, MyD88 and NF-κB p65 proteins.

Conclusions

It is suggested that the anti-inflammatory effect of atorvastatin on TNBS-induced rat colitis may involve the inhibition of the TLR4/NFkB signaling pathway.

Aderem A (2001) Role of toll-like receptors in inflammatory response in macrophages. Crit Care Med 29:S16–S18CrossRefPubMed

Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406:782–787CrossRefPubMed

Aktunc E, Kayhan B, Arasli M, Gun BD, Barut F (2011) The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis. Immunopharmacol Immunotoxicol 33:667–675CrossRefPubMed

Allred D, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathol Off J US Can Acad Pathol Inc 11:155–168

Brubaker SW, Bonham KS, Zanoni I, Kagan JC (2015) Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol 33:257–290CrossRefPubMed

Cario E (2010) Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 16:1583–1597CrossRefPubMedPubMedCentral

Deshmukh C, Veeresh B, Pawar A (2010) Protective effect of emblica officinalis fruit extract on acetic acid induced colitis in rats. J Herbal Med Toxicol 4:83–87

Dhamija P, Hota D, Kochhar R, Sachdev A, Chakrabarti A (2014) Randomized clinical trial: atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis. Indian J Gastroenterol 33:151–156CrossRefPubMed

Didierlaurent A, Sirard JC, Kraehenbuhl JP, Neutra MR (2002) How the gut senses its content. Cell Microbiol 4:61–72CrossRefPubMed

Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Ann Rev Immunol 20:197–216CrossRef

Ke X et al (2013) Qing hua chang yin exerts therapeutic effects against ulcerative colitis through the inhibition of the tlr4/nf-κb pathway. Int J Mol Med 32:926–930PubMed

Khan I, Oriowo MA, Anim JT (2005) Amelioration of experimental colitis by na-h exchanger-1 inhibitor amiloride is associated with reversal of il-1β and erk mitogen-activated protein kinase. Scand J Gastroenterol 40:578–585CrossRefPubMed

Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77:598–625CrossRefPubMed

Kojouharoff G, Hans W, Obermeier F, Andus T, Gross V, Falk W (1997) Neutralization of tumour necrosis factor (tnf) but not of il-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 107:353–358CrossRefPubMedPubMedCentral

Lee JY, Kim JS, Kim JM, Kim N, Jung HC, Song IS (2007) Simvastatin inhibits nf-κb signaling in intestinal epithelial cells and ameliorates acute murine colitis. Int Immunopharmacol 7:241–248CrossRefPubMed

Li M-C, He S-H (2004) Il-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol 10:620–625CrossRefPubMedPubMedCentral

Lin S et al (2012) Heme activates tlr4-mediated inflammatory injury via myd88/trif signaling pathway in intracerebral hemorrhage. J Neuroinflammation 9:46CrossRefPubMedPubMedCentral

Maron DJ, Fazio S, Linton MF (2000) Current perspectives on statins. Circulation 101:207–213CrossRefPubMed

Molodecky NA et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142(46–54):e42PubMed

Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795–803PubMed

Mukhopadhya A, Gilmour H, Plevris J (2008) Pravastatin-induced colitis. Eur J Gastroenterol Hepatol 20:810–812CrossRefPubMed

Naito Y et al (2006) Rosuvastatin, a new hmg-coa reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. Int J Mol Med 17:997–1004PubMed

Ohkawara T et al (2006) Regulation of toll-like receptor 4 expression in mouse colon by macrophage migration inhibitory factor. Histochem Cell Biol 125:575–582CrossRefPubMed

Pålsson-McDermott EM, O’Neill LA (2004) Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4. Immunology 113:153–162CrossRefPubMedPubMedCentral

Rashidian A, Roohi P, Mehrzadi S, Ghannadi AR, Minaiyan M (2015) Protective effect of ocimum basilicum essential oil against acetic acid–induced colitis in rats. J Evid Based Complement Altern Med 2156587215616550

Rea W, Durrant D, Boldy D (2002) Ulcerative colitis after statin treatment. Postgrad Med J 78:286–287CrossRefPubMedPubMedCentral

Rutgeerts P (1999) Review article: efficacy of infliximab in crohn’s disease—induction and maintenance of remission. Aliment Pharmacol Ther 13:9–15CrossRefPubMed

Sasaki M et al (2003) The 3-hydroxy-3-methylglutaryl-coa reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis. J Pharmacol Exp Ther 305:78–85CrossRefPubMed

Scheiffele F,Fuss IJ (2002) Induction of tnbs colitis in mice Curr Protoc immunol 15.19. 11–15.19. 14

Szebeni B et al (2008) Increased expression of toll-like receptor (tlr) 2 and tlr4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immunol 151:34–41CrossRefPubMedPubMedCentral

Tan J, Pretorius CF, Flanagan PV, Pais A (2012) Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman. BMJ Case Reports 2012:bcr1120115270

Teng X, Xu L-F, Zhou P, Sun H-W, Sun M (2009) Effects of trefoil peptide 3 on expression of tnf-α, tlr4, and nf-κb in trinitrobenzene sulphonic acid induced colitis mice. Inflammation 32:120–129CrossRefPubMed

Ungaro R et al (2009) A novel toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol 296:G1167–G1179CrossRefPubMedPubMedCentral

Wang K, Wan YJY (2008) Nuclear receptors and inflammatory diseases. Exp Biol Med 233:496–506CrossRef

Wierzbicki AS, Poston R, Ferro A (2003) The lipid and non-lipid effects of statins. Pharmacol Therap 99:95–112CrossRef

Zeng Z, Zhan L, Liao H, Chen L, Lv X (2013) Curcumin improves tnbs-induced colitis in rats by inhibiting il-27 expression via the tlr4/nf-κb signaling pathway. Planta Med 79:102–109PubMed

Zhang S, Zhao X, Zhang D (2014) Cellular and molecular immunopathogenesis of ulcerative colitis. Cell Mol Immunol 11:314CrossRefPubMedCentral

Title: Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway
Authors: Amir Rashidian
Ahad Muhammadnejad
Ahmad-Reza Dehpour
Shahram Ejtemai Mehr
Maziar Mohammad Akhavan
Reza Shirkoohi
Mohsen Chamanara
Seyyedeh-Elaheh Mousavi
Seyed-Mahdi Rezayat
Publication date: 01-06-2016
Publisher: Springer International Publishing
Published in: Inflammopharmacology / Issue 2-3/2016
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-016-0263-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway

Abstract

Aim

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Aim

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2-3/2016

Chemical composition of Nigella sativa Linn: Part 2 Recent advances

The antioxidant activity of some curcuminoids and chalcones

Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-κB and oxidative stress

Helicobacter pylori-elicited induction in gastric mucosal matrix metalloproteinase-9 (MMP-9) release involves ERK-dependent cPLA2 activation and its recruitment to the membrane-localized Rac1/p38 complex

Alkylglycerols reduce serum complement and plasma vascular endothelial growth factor in obese individuals

Role of protein kinase D2 phosphorylation on Tyr in modulation by ghrelin of Helicobacter pylori-induced up-regulation in gastric mucosal matrix metalloproteinase-9 (MMP-9) secretion